InvestorsHub Logo
Followers 101
Posts 13186
Boards Moderated 0
Alias Born 06/01/2013

Re: Staypositive1 post# 9988

Friday, 10/19/2018 1:54:20 PM

Friday, October 19, 2018 1:54:20 PM

Post# of 27660
Gilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug

https://seekingalpha.com/article/4187810-gileads-hiv-franchise-assault-stares-paradigm-changing-drug

Other drug makers like GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), and Bristol-Myers Squibb (BMY) round out the top 11 drugs for HIV and are looking for cracks in GILD’s HIV franchise to exploit. They are likely meeting with CYDY in anticipation of the approval, and if they get wind of a monotherapy filing, this could spark a fight for control of the next generation of HIV treatment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News